Portal de Periódicos da CAPES

Risk Factors of Mortality After Liver Transplantation in Uruguay

2018; Elsevier BV; Volume: 50; Issue: 2 Linguagem: Inglês

10.1016/j.transproceed.2017.12.036

1873-2623

Daniela Olivarí, Victoria Mainardi, Karina Rando, Gabriela Rey, J. Carlos Menéndez, Jhon Prieto, Juan Francisco Medina Gallardo, Marcelo Valverde, Jorge Castelli, G. Grecco, Alejandro Leites, Graciela Zunini, S. Gozalez, Martín Harguindeguy, Solange Gerona,

Renal Transplantation Outcomes and Treatments

Identification of predictive factors of mortality in a liver transplant (LT) program optimizes patient selection and allocation of organs. To determine survival rates and predictive factors of mortality after LT in the National Liver Transplant Program of Uruguay. A retrospective study was conducted analyzing data prospectively collected into a multidisciplinary database. All patients transplanted since the beginning of the program on July 2009 to April 2017 were included (n = 148). Twenty-nine factors were analyzed through the univariate Kaplan-Meier model. A Cox regression model was used in the multivariate analysis to identify the independent prognostic factors for survival. Overall survival was 92%, 87%, and 78% at discharge, 1 year, and 3 years, respectively. The Kaplan-Meier survival curves were significantly lower in: recipients aged >60 years, Model for End-Stage Liver Disease score >21, LT due to hepatocellular carcinoma (HCC) and acute liver failure (ALF), donors with comorbidities, intraoperative blood loss beyond the median (>2350 mL), red blood cell transfusion requirement beyond the median (>1254 mL), intraoperative complications, delay of extubation, invasive bacterial, and fungal infection after LT and stay in critical care unit >4 days. The Cox regression model (likelihood ratio test, P = 1.976 e−06) identified the following independent prognostic factors for survival: LT for HCC (hazard ratio [HR] 4.511; P = .001) and ALF (HR 6.346; P = .004), donors with comorbidities (HR 2.354; P = .041), intraoperative complications (HR 2.707; P = .027), and invasive fungal infections (HR 3.281; P = .025). The survival rates of LT patients as well as the mortality-associated factors are similar to those reported in the international literature.